Wave Life Sciences' WVE-007: A Promising New Player in Obesity Treatment

TipRanksDec 25 19:55

Express News | Wave Life Sciences Ltd - Expects First-in-Human Study of Wve-007 in Q1 2025

BreakingsDec 23 21:31

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (SiRNA Targeting INHBE) in Obesity

GlobeNewswireDec 23 21:30

Express News | Wave Life Sciences Announces Submission of First Clinical Trial Application for Wve-007 (Sirna Targeting Inhbe) in Obesity

BreakingsDec 23 21:30

PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16 22:56

Buy Rating for Wave Life Sciences: Favorable Regulatory Environment and Promising WVE-003 Data

TipRanksDec 12 12:55 · Ratings